Replies to post #14377 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

MNTA hires BIIB executive for COO position:

http://finance.yahoo.com/news/momenta-pharmaceuticals-appoints-matthew-p-153000611.html

Momenta Pharmaceuticals, Inc….today announced the appointment of Matt Ottmer as Chief Operating Officer.

…Mr. Ottmer most recently served as Senior Vice President, Strategy & Emerging Businesses at Biogen, Inc. where he led cross-functional assessment, prioritization, and implementation planning across a broad range of value-creating opportunities including internal capability building, alliances and in-licenses, and mergers and acquisitions. Before his promotion to Senior Vice President, Mr. Ottmer held positions of increasing responsibility at Biogen from 1999 to 2015 including Head of Tysabri Business, Chief of Staff to the CEO, President of Syntonix Pharmaceuticals, Inc. (a wholly owned subsidiary of Biogen), and Vice President, Global Operations. He received a Bachelor of Arts degree in political science from the University of Michigan and a Master’s in Business Administration from Northwestern University’s Kellogg School of Management.

MNTA hasn’t had a COO since 2010 (when Steven Brugger left to become CEO of Visterra Pharmaceuticals).